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Universal Masking in the United States
The Role of Mandates, Health Education, and the CDC
The Centers for Disease Control and Prevention (CDC)
recommends cloth face coverings in public settings to
prevent spread of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coro-
navirus disease 2019 (COVID-19). Face coverings de-
crease the amount of infectious virus exhaled into the
environment, reducing the risk an exposed person will
become infected.1 Although many states and localities
have ordered mask use, considerable variability and
inconsistencies exist. Would a national mandate be an
effective COVID-19 prevention strategy, and would it be
lawful? Given the patchwork of state pandemic re-
sponses, should the CDC have enhanced funding and
powers to forge a nationally coordinated response to
COVID-19 and to future health emergencies?
Evidence Supporting Population-Based
Face Coverings
In early February 2020, the CDC recommended mask
use for anyone exhibiting COVID-19–like symptoms to
reduce the spread of respiratory droplets.2 On April 3,
2020, following recognition that viral load is high just
before and early in the course of COVID-19 disease, the
agency expanded its recommendation, urging mask
use by the general public. Face masks significantly
reduce detection of influenza virus RNA in respiratory
droplets and coronavirus RNA in aerosols.3 In a large
health care system, a policy of universal masking was
associated with steady declines in COVID-19–positive
tests.4 An evaluation of state policies showed greater
declines in daily COVID-19 cases after issuing mask
mandates compared with states that did not have
mandates.5 Face coverings offer source control to pre-
vent exposing others and may offer protection to
users. The ethical justification for face coverings is their
utility in preventing transmission of serious disease to
community members.
Mask Mandates: Lawfulness, Compliance, Utility
As of July 27, 2020, statewide orders mandating face
coverings in response to COVID-19 had been issued in
31 states and the District of Columbia. Mandates vary, in-
cluding directives to the general public, specific types of
businesses, and to employers, employees, or both (see
Table in Supplement 1). Most states grant exemptions for
individuals with medical conditions or disabilities that
render it difficult to wear face coverings.
States undoubtedly have the power to require mask
use. Yet because face coverings have become associ-
ated with political or other symbolic meaning, some have
challenged mandates as violating the First Amendment.
A federal district court in Maryland rejected this argu-
ment, holding that wearing a face covering simply con-
veys the idea that masks protect the public, nothing more.
The US Supreme Court recently upheld COVID-19 restric-
tions on religious worship as a valid public health
measure,6 and similar reasoning could apply to masks. The
Occupational Safety and Health Administration also per-
mits employers to require face coverings to abate the
spread of SARS-CoV-2. Similarly, businesses can require
customers to use masks as a condition of service.
Despite the prevalence of lawful orders, masks are
not required in many parts of the United States, lead-
ing to a patchwork of protection. Georgia’s governor, for
example, issued an executive order preempting local
mask mandates.7 In states without mask require-
ments, there is considerable local variation in mask use.
With intrastate and interstate travel, the lack of unifor-
mity and consistency has proven to be an obstacle to
progress in the COVID-19 crisis.
Although a federal mask mandate
may appear to be an attractive policy, it
could encounter legal challenges, be dif-
ficult to enforce, and further politicalize
wearing of masks. It is not clear whether
the CDC has the authority to mandate
face coverings nationwide. The Public
Health Service Act grants the CDC pow-
ers to detain and medically examine potentially in-
fected persons arriving into the United States and trav-
eling between states, but this authority is unlikely to
extend to regulatory actions such as requiring masks.
Congress probably could enact a national mandate un-
der the commerce power but has not done so. A fed-
eral mandate, moreover, might provoke political oppo-
sition to face coverings rooted in state sovereignty.
A better way to gain more national uniformity is
by inducing states to enact mask laws. This respects
states as key decision makers in public health and is
more consistent with state autonomy. It is also easier
to gain compliance with state and local directives rather
than using federal officers to monitor and enforce a na-
tional mandate.
A well-crafted use of federal spending powers
would likely be constitutional. Congress could attach
conditions on the receipt of federal funds, inducing
states to adopt a mandate. Intoxicated driver laws offer
an analogy. The Supreme Court upheld a federal law
The ethical justification for face
coverings is their utility in preventing
transmission of serious disease
to community members.
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conditioning 5% of highway funds on states adopting a 21-year-old
drinking age.8 The court probably would similarly uphold a fed-
eral law designating a reasonable portion of COVID-19 emergency
funding on the condition that states issue mask directives. It is
possible, however, that some states would reject a mask man-
date, thus doubly jeopardizing their residents’ health—no funding
and no mask mandate.
Face Coverings as Part of a Comprehensive COVID-19
Prevention Strategy
Law can be a powerful tool for encouraging health behaviors. Laws
requiring seatbelts offer a good analogy. Despite early opposition, the
public came to regard passenger restraints as minimally invasive and
vital safety features. Mask orders similarly could gain public accep-
tance because they are designed to protect mask wearers and the
wider community. Mask laws cannot be successful alone but should
be combined with a well-funded and well-designed health educa-
tion campaign. Comprehensive and consistent public messaging is es-
sential: “when we all mask up, we are all safer.” A well-crafted mes-
sage addressing the common good could significantly increase mask
use, changing social norms to achieve near universal compliance.
CDC Funding and Powers in Health Emergencies:
Time for a Reassessment?
When the history of COVID-19 is written, the role of the CDC will come
under particular scrutiny. The most important conversation now is
how to proactively prepare for the next pandemic. What funding,
powers, and independence did the agency lack that could have made
a difference?
Historically, states and localities have assured the public’s health,
with the CDC providing funding, technical guidance, and coordina-
tion. National coordination is achieved as states adopt evidence-
based recommendations from the CDC. This model, however, breaks
down if the federal government does not consistently support the
CDC and the science undergirding its guidelines.
The state-by-state approach, moreover, is ill suited to health
emergencies, which spill over to adjoining states, even the entire
country. National leadership and a national plan are required. As
mask use illustrates, state policies rapidly and forcefully affect US
regions and the United States overall. States that reopened too
soon experienced surges in COVID-19 cases, which spread across
state borders. The CDC principally derives its powers from the Pub-
lic Health Service Act, enacted in 1944. Congress could not have
anticipated the complex national response pandemics like
COVID-19 demand, including testing, contact tracing, stay-at-home
orders, and a national health information system. In planning for
the next pandemic, Congress should consider affording the CDC
with flexible powers to ensure a uniform, well-coordinated
response to prevent interstate spread of novel diseases.
COVID-19 teaches other lessons, including the importance of
ample health funding, greater autonomy of public health agen-
cies, and preserving the integrity of science. As the Institute of
Medicine recommended for the Food and Drug Administration
commissioner, the CDC director could be appointed to a 6-year
cross-administration term, mirroring the heads of the National
Science Foundation and Social Security Administration.9 Yet even
a 6-year term may not ensure CDC independence in a highly
partisan political environment. An unreceptive White House or
Congress can easily subvert science-based policy. The CDC also
needs greater budgetary independence. Like the Social Security
Administration, the CDC should submit its budget requests
directly to Congress without the President being able to alter that
budget before submission.10 Congress should also create an
emergency fund, enabling a surge response without prior con-
gressional approval.
The CDC’s mission of safeguarding US health security through
the application of science is of the highest importance to US resi-
dents. The COVID-19 pandemic offers a rare opportunity to
strengthen that agency, affording the CDC the authority, funding,
and independence necessary for a healthy and safe population.
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